Epoetin alfa: patient management
Anna Journal 16(5): 348-350
1989
ISSN/ISBN: 8750-0779 PMID: 2774689 Document Number: 340808
Nurses play an integral role in managing the patient receiving Epoetin alfa. Patient parameters, such as blood pressure and hematocrit, must be continually monitored to assure the effectiveness of the medication.
Document emailed within 1 workday
Related Documents
Morley, C.T. 1993: Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa Anna Journal 20(5): 604-607Keen, M.L. 1990: Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing Anna Journal 17(4): 318-319
Kammerer, J.K. 1994: Case study of the anemic patient: epoetin alfa--focus on protocols Anna Journal 21(7): 440-443
Cohen, J.A.; Brattich, M. 1997: Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient Anna Journal 24(5): 574-580; Quiz 581
Shanahan, M.; Walton, S. 1995: Developing an epoetin alfa medication protocol to improve patient care and foster collaboration Anna Journal 22(5): 471-476
Martin-Lester, M. 1996: Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient Anna Journal 23(6): 630-633
Cohen, J.A.; Brattich, M. 1997: Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient Anna Journal 24(5): 574-580; Quiz 581
Bachmann, G.A. 2001: Epoetin alfa use in gynecology. Past, present and future Journal of Reproductive Medicine 46(5 Suppl): 539-544
Bieber, E. 2001: Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview Journal of Reproductive Medicine 46(5 Suppl): 521-530
Lacina, N.C. 1991: Exercise tolerance before and after correction of anemia with epoetin alfa American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 17(2): 245
Faris, P.M.; Ritter, M.A. 1998: Epoetin alfa. a bloodless approach for the treatment of perioperative anemia Clinical Orthopaedics and Related Research 357: 60-67
Rieger, P.T.; Haeuber, D. 1995: A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa Oncology Nursing Forum 22(1): 71-81
Voravud, N.; Sriuranpong, V.; Suwanrusme, H. 2007: Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy Journal of the Medical Association of Thailand 90(6): 1082-1088
Campistol, J.M.; Carreño, Aín.; Morales, Jé.M.; Pallardó, L.; Franco, A.; Navarro, D.; Grinyó, J.M.; Montenegro, Jús.; Sánchez Fructuoso, A.I.; Romero, Rón.; Guirado, L.; Arias, M.; Nieto-Iglesias, J.; Esforzado, N.; Beltrán-Catalán, S.; Gómez-Alamillo, C.; Lauzurica, R.; Bengoa, I.; Facundo-Molas, C. 2013: Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial Transplantation 95(2): E6
Thanakitcharu, P.; Siriwiwatanakul, N. 2007: Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia Journal of the Medical Association of Thailand 90(12): 2574-2586
Voravud, N.; Sriuranpong, V. 2005: Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy Journal of the Medical Association of Thailand 88(5): 607-612
Veys, N.; Dhondt, A.; Lameire, N. 1998: Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clinical Nephrology 49(1): 41-44
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72